Synthesis and evaluation of different fatty acid esters formulated into Precirol® ATO-based lipid nanoparticles as vehicles for topical delivery

Chemical and Pharmaceutical Bulletin

Volumn 57, Issue 7, 2009, Pages 680-684

  Sanna, Vanna ^a   Mariani, Alberto ^b   Caria, Giuseppe ^b   Sechi, Mario ^b  

^a Prion DGN C/o Porto Conte Research Centre   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

Author keywords

Econazole nitrate; Fatty acid ester; Lipid nanoparticle; Skin permeation

Indexed keywords

DRUG VEHICLE; ECONAZOLE; FATTY ACID ESTER; GLYCEROL PALMITOSTEARATE; LIPID; NANOPARTICLE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SYNTHESIS; ENCAPSULATION; EX VIVO STUDY; HYDROGEL; NONHUMAN; SKIN PERMEABILITY; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; ANTIFUNGAL AGENTS; CALORIMETRY, DIFFERENTIAL SCANNING; DIGLYCERIDES; DRUG COMPOUNDING; ECONAZOLE; FATTY ACIDS; LIPIDS; NANOPARTICLES; PERMEABILITY; SKIN; SWINE;

EID: 67650809722     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.57.680     Document Type: Article

References (31)

1. Santos Maia C., Mehnert W., Schaller M., Korting H. C., Gysler A., Haberland A., Schafer-Korting M., J. Drug Target, 10, 489-495 (2002).
2. Sivaramakrishnan R., Nakamura C., Mehnert W., Korting H. C., Kramer K. D., Schafer-Korting M., J. Controlled Release, 97, 493-502 (2004).
3. Lombardi Borgia S., Regehly M., Sivaramakrishnan R., Mehnert W., Korting H. C., Danker K., Roder B., Kramer K. D., Schafer-Korting M., J. Controlled Release, 110, 151-163 (2005).
4. Muller R. H., Radtke M., Wissing S. A., Adv. Drug Deliv. Rev., 54, S131-155 (2002).
5. Souto E. B., Wissing S. A., Barbosa C. M., Muller R. H., Int. J. Pharm., 278, 71-77 (2004).
6. Castelli F., Puglia C., Sarpietro M. G., Rizza L., Bonina F., Int. J. Pharm., 304, 231-238 (2005).
7. Souto E. B., Wissing S. A., Barbosa C. M., Muller R. H., Eur. J. Pharm. Biopharm., 58, 83-90 (2004).
8. Benson H. A. E., Curr. Drug Deliv., 2, 23-33 (2005).
9. Mehnert W., Mader K., Adv. Drug Deliv. Rev., 47, 165-196 (2001).
10. Hu F. Q., Jiang S. P., Du Y. Z., Yuan H., Ye Y. Q., Zeng S., Coll. Surf. B: Biointerfaces, 45, 167-173 (2005).
11. Hu F. Q., Jiang S. P., Du Y. Z., Yuan H., Ye Y. Q., Zeng S., Int. J. Pharm., 314, 83-89 (2006).
12. Tanojo H., Bouwstra J. A., Junginger H. E., Bodde H. E., Pharm. Res., 14, 42-49 (1997).
13. Fujii M., Hori N., Shiozawa K., Wakabayashi K., Kawahara E., Matsumoto M., Int. J. Pharm., 205, 117-125 (2000).
14. Santoyo S., Ygartua P., Eur. J. Pharm. Biopharm., 50, 245-250 (2000).
15. Trommer H., Neubert R. H., Skin Pharmacol. Physiol., 19, 106-121 (2006).
16. Elyan B. M., Sidhom M. B., Plakogiannis F. M., J. Pharm. Sci., 85, 101-105 (1996).
17. Takeuchi Y., Yamaoka Y., Fukushima S., Miyawaki K., Taguchi K., Yasuka H., Kishimoto S., Suzuki M., Biol. Pharm. Bull., 21, 484-491 (1998).
18. Bhatia K. S., Singh J., J. Pharm. Sci., 87, 462-469 (1998).
19. Sanna V., Gavini E., Cossu M., Rassu G., Giunchedi P., J. Pharm. Pharmacol., 59, 1057-1064 (2007).
20. Simon G. A., Maibach H. I., Skin Pharmacol. Appl. Skin Physiol., 13, 229-234 (2000).
21. Benech-Kieffer F., Wegrich P., Schwarzenbach R., Klecak G., Weber T., Leclaire J., Schaefer H., Skin Pharmacol. Appl. Skin Physiol., 13, 324-335 (2000).
22. Vaddi H. K., Ho P. C., Chan Y. W., Chan S. W., J. Controlled Release, 81, 121-133 (2002).
23. Parrish J. P., Dueno E. E., Kim S.-I., Jung K. W., Synth. Comm., 30, 2687-2700 (2000).
24. Vandevoorde S., Tsuboi K., Ueda N., Jonsson K. O., Fowler C. J., Lambert D. M., J. Med. Chem.. 46, 4373-4376 (2003).
25. Awang R., Basri M., Sallah A. B., J. Am. Oil Chem. Soc., 77, 609-612 (2000).
26. Sekeroglu G., Fadiloglu S., Ibanoglu E., Turkish J. Eng. Env. Sci., 28, 241-247 (2004).
27. Jenning V., Gohla S. H., J. Microencapsul., 18, 149-158 (2001).
28. Jenning V., Thunemann A. F., Gohla S. H., Int. J. Pharm., 199, 167-177 (2000).
29. Godefroi E. F., Heeres J., Van Cutsem J., Janssen P. A., J. Med. Chem., 12, 784-791 (1969).
30. Fang J. Y., Fang C. L., Liu C. H., Su Y. H., Eur. J. Pharm. Biopharm., 70, 633-640 (2008).
31. Kadir R., Stempler D., Liron Z., Cohen S., J. Pharm. Sci., 76, 774-779 (1987).